"We felt Unilife were extremely responsive to our requirements"
Click here for the full article
This seems to be the feedback coming through now with those we sign deals with, Medimmune went through around 30 potentials and chose Unilife, Hikma, as above article states, also went through multiple options before choosing Unilife. Obviously Sanofi have been working with us for many years and are willing to house Lovenox in our syringes, it wont be long for the others to follow in fear of their drug indications being snapped up by others.
Even the market is catching on now:)
- Forums
- ASX - By Stock
- "we felt unilife were extremely responsive"
"We felt Unilife were extremely responsive to our...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)